Heart disease that appears identical to a heart attack but resolves on its own represents one of cardiology's most underappreciated diagnostic traps. Takotsubo syndrome — triggered by acute emotional or physical stress — affects tens of thousands annually, disproportionately postmenopausal women, yet continues to evade timely and accurate diagnosis, potentially delaying appropriate care or, conversely, triggering unnecessary interventions.
This review in the Journal of Clinical Medicine systematically maps the diagnostic terrain surrounding Takotsubo syndrome (TTS), examining why distinguishing it from acute coronary syndrome, myocarditis, and other cardiomyopathies remains so difficult in practice. The authors assess the InterTAK diagnostic framework — the most widely used clinical scoring system for TTS — and find that even this structured approach leaves meaningful ambiguity. Left ventricular wall motion abnormalities in TTS follow patterns that can be transient and variable, biomarker profiles overlap substantially with myocardial infarction, and ECG changes mirror those of ST-elevation events. The review highlights multimodal cardiac imaging, including cardiac MRI with late gadolinium enhancement, as the most discriminating tool currently available, while also flagging the emerging role of machine learning algorithms in pattern recognition across large echocardiographic and biomarker datasets.
From a broader clinical perspective, TTS sits at a frustrating intersection: it is physiologically benign in most cases yet carries acute-phase mortality risk approaching that of true myocardial infarction, particularly when complicated by cardiogenic shock or ventricular arrhythmia. The catecholamine surge hypothesis — whereby surging norepinephrine causes direct myocardial toxicity and microvascular spasm — remains the dominant mechanistic model, though neurogenic, inflammatory, and hormonal axes are increasingly implicated, especially given the female predominance. This is a high-quality narrative review rather than a primary data study, limiting it from establishing new causal or epidemiological conclusions. Its value lies in synthesis and clinical guidance, making it most actionable for hospital-based cardiologists managing undifferentiated chest pain. The AI-assisted diagnostic angle, while promising, lacks validated prospective trial evidence at this stage.